Journal of the Neurological Sciences
Volume 223, Issue 2 , Pages 113-119 , 30 August 2004

Expression of the interferon-α/β-inducible MxA protein in brain lesions of subacute sclerosing panencephalitis

  • Seiko Ogata

      Affiliations

    • Present address: Department of Internal Medicine, Hokkaido University Graduate School of Medicine, North-14, West-5, Kita-ku, Sapporo, 060-8648, Japan.
    • ,
  • Akihiko Ogata

      Affiliations

    • Corresponding Author InformationCorresponding author. Present address: Department of Neurology, Hokkaido University Graduate School of Medicine, North-14, West-5, Kita, Sapporo, 060-8648,Japan. Tel.: +81-11-716-1161; fax: +81-11-700-5356.
    • ,
  • Sybille Schneider-Schaulies
    • ,
  • Jürgen Schneider-Schaulies

Received 21 January 2004 ,Revised 20 April 2004 ,Accepted 21 April 2004.

References 

  1. ter Meulen V, Stephenson JR, Kreth HW. Subacute sclerosing panencephalitis. In:  Fraenkel-Conrat H,  Wagner RR editor. Comprehensive Virology. vol. 18:New York: Plenum; 1983;p. 105–159
  2. Schneider-Schaulies S, Schneider-Schaulies J, Dunster LM, ter Meulen V. Measles virus gene expression in neural cells. In:  Billeter MA,  Ter Meulen V editor. Current Topics of Microbiology and Immunology (CTMI). vol. 191:1995;p. 101–116
  3. Baczko K, Liebert UG, Billeter MA, Cattaneo R, Budka H, ter Meulen V. Expression of defective measles virus genes in brain tissues of patients with subacute sclerosing panencephalitis. J. Virol. 1986;59:472–478
  4. Cattaneo R, Rebmann G, Schmid A, Bczko K, ter Meulen V, Billeter MA. Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J. 1987;6:681–687
  5. Liebert UG, Baczko K, Budka H, ter Meulen V. Restricted expression of measles virus proteins in brains from cases of subacute sclerosing panencephalitis. J. Gen. Virol. 1986;67:2435–2444
  6. Schneider-Schaulies S, Liebert UG, Baczko K, Cattaneo R, Billeter MA, ter Meulen V. Restriction of measles virus gene expression in acute and subacute encephalitis of Lewis rats. Virology. 1989;171:525–534
  7. Schneider-Schaulies S, ter Meulen V. Molecular aspects of measles virus induced central nervous system diseases. In:  Roos RP editors. Molecular Neurovirology. Totowa, New Jersey: Humana Press; 1992;p. 419–449
  8. McQuaid S, Campbell R, Isserte S, Cosby SL. Leukaemia inhibitory factor mRNA is expressed in the brains of patients with subacute sclerosing panencephalitis. J. Neuroimmunol. 1997;77:57–62
  9. Nagano I, Nakamura S, Yoshioka M, Onodera J, Kogure K, Itoyama Y. Expression of cytokines in brain lesions in subacute sclerosing panencephalitis. Neurology. 1994;44:710–715
  10. Schneider-Schulies J, Schneider-Schaulies S, ter Meulen V. Differential induction of cytokines by primary and persistent measles virus infections in human glial cells. Virology. 1993;195:219–228
  11. Ponten A, Sick C, Weeber M, Haller O, Kochs G. Dominant-negative mutants of human MxA protein: domains in the carboxy-terminal moiety are important for oligomerization and antiviral activity. J. Virol. 1997;71:2591–2599
  12. Schneider-Schaulies S, Schneider-Schaulies J, Schuster A, Bayer M, Pavlovic J, Ter Meulen V. Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells. J. Virol. 1994;69:6910–6917
  13. Schuster A, Johnston ICD, Das T, Banerjee AK, Pavlovic J, ter Meulen V, et al.  Expression of the human MxA protein is associated with hyperphosphorylation of the VSV-P protein in human neural cells. Virology. 1996;220:241–245
  14. Staeheli P. Interferon-induced proteins and the antiviral state. Adv. Virus Res. 1990;38:147–200
  15. Staeheli P, Pitossi F, Pavlovic J. Mx proteins: GTPases with antiviral activity. Trends Biochem. Sci. 1993;3:268–272
  16. Horisberger MA. Interferon-induced human protein MxA is a GTPase which binds transiently to cellular proteins. J. Virol. 1992;66:4705–4709
  17. Horisberger MA, Staeheli P, Haller O. Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus. Proc. Natl. Acad. Sci. U. S. A. 1983;80:1910–1914
  18. Pavlovic J, Staeheli P. The antiviral potentials of Mx proteins. J. Interf. Res. 1991;11:215–219
  19. Richter MF, Schwemmle M, Herrnann C, Wittinghofer A, Staeheli P. Interferon-induced MxA protein. GTP binding and GTP hydrolysis properties. J. Biol. Chem. 1995;270:13512–13517
  20. Schwemmle M, Weining KC, Richter MF, Schumacher B, Staeheli P. Vesicular stomatitis virus transcription inhibited by purified MxA protein. Virology. 1995;206:545–554
  21. Pavlovic J, Zürchner T, Haller O, Staeheli P. Resitence to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J. Virol. 1990;64:3370–3375
  22. Zürcher T, Pavlovic J, Staeheli P. Mechanism of human MxA protein action: variants with changed antiviral properties. EMBO J. 1992;11:1657–1661
  23. Frese M, Kochs G, Meier-Dieter U, Siebler J, Haller O. Human MxA protein inhibits Tick-Borne Thogoto virus but not Dhori virus. J. Virol. 1995;69:3904–3905
  24. Staeheli P, Pavlovic J. Inhibition of vesicular stomatits virus mRNA synthesis by human MxA protein. J. Virol. 1991;65:4498–4501
  25. Landis H, Simon-Jödicke A, Klöti A, Di Paolo C, Schnorr JJ, Schneider-Schaulies S, et al.  Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins. J. Virol. 1998;72:1516–1522
  26. Schnorr JJ, Schneider-Schaulies S, Simon-Jödicke A, Pavlovic J, Horisberger MA, ter Meulen V. MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line. J. Virol. 1993;67:4760–4768
  27. Nakayama M, Nagata K, Kato A, Ishihama A. Interferon-inducible mouse Mx1 protein that confers resistance to influenza virus is a GTPase. J. Biol. Chem. 1991;266:21404–21408
  28. Zürcher T, Pavlovic J, Staeheli P. Nuclear localization of mouse Mx1 protein is necessary for inhibition of influenza virus. J. Virol. 1992;66:5059–5066
  29. Meier E, Kunz G, Haller O, Arnheiter H. Activity of rat Mx proteins against a rhabdovirus. J. Virol. 1990;64:6263–6269
  30. Kanerva M, Melén K, Vaheri A, Julkunen I. Inhibition of Puumala and Tula-Hantavirus in vero cells by MxA protein. Virology. 1996;224:55–62
  31. Fäh J, Pavlovic J, Burg G. Expression of MxA protein in inflammatory dermatoses. J. Histochem. Cytochem. 1995;43:47–52
  32. Ronni T, Melen K, Malygin A, Julkunnen I. Control of IFN-inducible MxA gene expression in human cells. J. Immunol. 1993;150:1715–1726
  33. Baczko K, Lampe J, Liebert UG, Brinckmann U, Meulen Vter, Pardowitz I, et al.  Clonal expansion of hypermutated measles virus in a SSPE brain. Virology. 1993;197:188–195
  34. Bancher C, Leitner H, Jellinger K, Eder H, Liszka U, Wegiel J, et al.  On the expression between measles virus and Alzheimer neurofibrillary tangles in subacute sclerosing panencephalitis. Neurobiol. Aging. 1996;17:527–533
  35. Iwasaki Y, Sako K, Tsunoda I, Ohara Y. Phenotypes of mononuclear cell infiltrates in human central nervous system. Acta Neuropathol. 1993;85:653–657
  36. Ogata A, Czub S, Ogata S, Cosby SL, McQuaid S, Budka H, et al.  Absence of measles virus receptor (CD46) in lesions of subacute sclerosing panencephalitis. Acta Neuropathol. 1997;94:444–449
  37. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, Macdonald S, et al.  Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem. 1984;32:219–229
  38. Mason DY, Sammons R. Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents. J. Clin. Pathol. 1978;31:454–460
  39. Hsu SM, Raine L, Fanger H. Use of avidin–biotin–peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 1981;29:577–580
  40. Mibayashi M, Nakad K, Nagata K. Promoted cell death of cells expressing human MxA by influenza virus infection. Microbiol. Immunol. 2002;46:29–36
  41. Allen IV, McQuaid S, McMahon J, Kirk J, McConnel R. The significance of measles virus antigen and genome distribution in the CNS in SSPE for mechanisms of viral spread and demyelination. J. Neuropathol. Exp. Neurol. 1996;55:471–480
  42. Iwasaki Y, Koprowski H. Cell to cell transmission of virus in the central nervous system. Lab. Invest. 1974;31:187–192
  43. Forster J, Schweizer M, Schumacher RF, Kaufmehl K, Lob S. MxA protein in infants and children with respiratory tract infection. Acta Paediatr. 1996;85:163–167
  44. Vallittu A-M, Halminen M, Peltoniemi J, et al.  Neutralizing antibodies reduce MxA protein induction in interferon-beta-1a-treated MS patients. Neurology. 2002;58:1786–1790
  45. Yamada T. Further observation on MxA-positive Lewy bodies in Parkinson's disease brain tissues. Neurosci. Lett. 1995;195:41–44
  46. Yamada T, Horisberger MA, Kawaguchi N, Moroo I, Toyoda T. Immunohistochemistry using antibodies to a-interferon and its induced protein, MxA, in Alzheimer's and Parkinson's disease brain tissues. Neurosci. Lett. 1994;181:61–64
  47. Gascon G, Yamani S, Crowell J, Stigsby B, Nester M, Kanaan I, et al.  Combined oral isoprinosine-intraventricular alpha-interferon therapy for subacute sclerosing panencephalitis. Brain Dev. 1993;15:346–355
  48. Huttenlocher PR, Picchietti DL, Roos RP, Cashmen NR, Horowitz B, Horowitz MS. Intrathecal interferon in subacute sclerosing panencephalitis. Ann. Neurol. 1986;19:303–305
  49. Yoshioka H, Nishimura O, Nakagawa M, Ochi M, Takeuchi Y, Tominaga M, et al.  Administration of human leukocyte interferon to patients with subacute sclerosing panencephalitis. Brain Dev. 1989;11:302–307

PII: S0022-510X(04)00127-3

doi: 10.1016/j.jns.2004.04.029

Journal of the Neurological Sciences
Volume 223, Issue 2 , Pages 113-119 , 30 August 2004

Article Tools

* Image Usage & Resolution